The T1DX-QI Presymptomatic T1D Monitoring Project aims to improve diabetes centers’ process for positive T1D autoantibody monitoring as part of routine clinical management. This project launched Q4 2023 is supported by a grant from Breakthrough T1D (formerly JDRF).
There are two participating T1DX-QI centers included: University of Florida (PI: Laura Jacobsen, MD) and Rady Children's Hospital (PI: Carla Demeterco-Berggren, MD, PHD).
Centers have created current state process maps and are testing various interventions to improve monitoring process.
Project results will be available Q4 2024/Q1 2025.
The T1DX-QI Screening Project aims to operationalize routine screening for stage 1 and stage 2 T1D as part of clinical management. This project launched Q1 2024 and is sponsored by an educational grant from Sanofi.
There are four participating centers included: University of Indiana (PI: Tamara Hannon, MD), Texas Children's Hospital (PI: Daniel DeSalvo MD), Ann and Robert H. Lurie Children’s (PI: Naomi Fogel, MD), and Children’s National (PI: Shideh Majidi, MD).
The centers have documented their current processes and identified challenges in screening for stage 1 and stage 2 T1D.
The centers will use a QI process to test new ideas and scale successful interventions.
Abstract submissions for the November Learning Session are still open. Please use this link to view submission details and use this link to submit your abstract to share your centers work. The deadline to submit abstracts is August 16th.
For additional questions please email qi@t1dexchange.org
Registration is Still Open!
The T1DX-QI November Learning Session will be held Monday, November 11, in Chicago, IL. The Learning Session will be a 1 day event this year.
Please use this link to view the FAQ. Please view these details before registering and use this link to register.
ADEPT 2024 Registration is Still Open!
We are very excited to share that T1D Exchange in collaboration with American Diabetes Association (ADA) will be hosting a new diabetes equity focused conference titled Achieving Diabetes Equity Practice Today (ADEPT). ADEPT 2024 will be held Tuesday and Wednesday, November 12-13 following the T1DX-QI Learning Session 2024 in Chicago, IL.
The conference objectives are to highlight equity best practices and practical strategies on all areas of diabetes, (prediabetes, type 1, type 2, gestational diabetes, and diabetes in pregnancy). We encourage members to attend and invite your colleagues.
Use this link to view the FAQ. Please view these details before registering and use this link to register.
For additional questions please email qi@t1dexchange.org
Friends for Life 2024
T1DX-QI was proud to support Children with Diabetes at the annual Friends for Life Conference in Orlando, Florida!
Holly Hardison from the T1DX-QI coordinating center as well as clinical members, including (Dr. Nana-Hawa Yayah Jones, Dr. Laura Jacobsen, and Marissa Town) were engaged in various sessions supporting children, young adult, and their families in latest diabetes research and care.
T1DX-QI Upcoming Presentations at ADCES 2024
T1DX-QI will be represented by 2 oral presentations at ADCES 2024, New Orleans August 8 -12, 2024 .
Title: Make Clinical Visits More Personal: Lead With Person-First and Strength-Based Approaches
Presenters: Holly Hardison, Nicole Rioles, MA, and Emily DeWit, MASL
Title: Reduce Inequities In Diabetes Outcomes in Ten Practical Steps
Presenter: Osagie Ebekozien, MD, MPH
Use this link to view all T1DX-QI publications and abstracts.
T1DX-QI 2024 Publications
We are excited to share that T1DX-QI now has published 20 manuscripts in 2024. Our most recent article is now live online. You can view all T1DX-QI publications and abstract using this link.
Title: Depression Rates in Youth With Type 1 Diabetes During the COVID-19 Pandemic: Data From the T1D Exchange Quality Improvement Collaborative
Authors: Alissa Roberts, Sarah Corathers. Robert Rapaport, Saketh Rompicherla, Shideh Majdi, Nicole Rioles, Osagie Ebekozien, Faisal Malik
There have been several newly asked questions on the internal member website. Please use this link to respond and see all questions.
New Questions:
Question:
Is anyone tracking the number of patients that order pumps but do not start them? If so, would you mind sharing what you’ve found? We are hoping to improve upon this at our clinic and catch those who got lost in the process, but are curious if there seems to be a general non-starter rate around all of the clinics.
What platform(s) are people using for device downloads these days. Do they integrate to EMR? With all the cloud based services for pumps the need for these are fewer, but not 0 at this time. Also if it pulls into EMR that would be cool.
Breakthrough T1D has a new research opportunity titled
"Development Of Devices And Drugs For Fully Automated Insulin Delivery At Meals." Letters of Intent are due September 17, 2024. Please use this link to view more information and view all open opportunities.
Researchers from Lurie Children's Hospital in Chicago are seeking your participation in a survey regarding appropriate timing for various diabetes topics and self-management skills for children and emerging adults with type 1 diabetes as well as information on your current patient education practices. Please use this link to complete the survey and share the survey with your division or any providers who take care of children or adolescents with type 1 diabetes.
Upcoming Committee Calls
Please email qi@t1dexchange.org if you would like to receive the invite for any of the upcoming committee calls.
.png?upscale=true&width=520&upscale=true&name=MicrosoftTeams-image%20(58).png)